Association of vitamin D status with novel hemogram-derived inflammatory indices in preterm infants Authors: Dilek Kurnaz, Ayşe Işıl Özsoy, Zeynep Üze Okay, Berker Okay, Burcu Cebeci, Hakan Çakır MD¹, Derya Büyükkayhan MD¹ Published: 2026 ABSTRACT AbstractBackgroundVitamin D plays an important role in immune regulation and inflammatory responses. Hemogram-derived inflammatory indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) have recently emerged as practical markers of systemic inflammation. However, data regarding the relationship between vitamin D status and these inflammatory indices in preterm infants are limited.ObjectiveTo evaluate the association between vitamin D levels and hemogram-derived inflammatory indices in preterm infants hospitalized in the neonatal intensive care unit.MethodsThis retrospective study included 212 preterm infants born at or below 34 weeks of gestation. Serum 25-hydroxyvitamin D [25(OH)D] levels obtained during the first postnatal week and complete blood count (CBC) parameters measured on the first day of life were analyzed. Infants were classified as vitamin D deficient (< 12 ng/mL), insufficient (12–20 ng/mL), or sufficient (≥ 20 ng/mL). Hemogram-derived inflammatory indices including NLR, PLR, monocyte-to-lymphocyte ratio (MLR), SII, SIRI, and AISI were calculated and compared between groups.ResultsThe mean vitamin D level was 15.4 ± 10.3 ng/mL. Vitamin D deficiency, insufficiency, and sufficiency were detected in 44.3%, 27.8%, and 27.8% of infants, respectively. No significant differences were observed among vitamin D groups regarding WBC (White Blood Cell), C-reactive protein (CRP), NLR, PLR, MLR, SII, SIRI, or AISI values (all p > 0.05). Similarly, no significant correlations were found between vitamin D levels and inflammatory indices. Infants born before 32 weeks’ gestation had significantly higher NLR, SII, SIRI, and AISI values compared with infants ≥ 32 weeks (all p < 0.01).ConclusionVitamin D status was not associated with hemogram-derived inflammatory indices in preterm infants, even after adjustment for relevant perinatal confounders. Further prospective studies are needed to clarify the relationship between vitamin D status and inflammatory profiles in this population.Keywords: Vitamin D, Prematurity, Inflammation, NLR, SII, Newborn Introduction Vitamin D is an essential hormone involved not only in calcium-phosphorus homeostasis and bone metabolism but also in regulation of the immune system and inflammatory responses [1]. Preterm infants are particularly vulnerable to vitamin D deficiency because of inadequate transplacental transfer during the third trimester, limited vitamin D stores at birth, insufficient enteral intake, and prolonged hospitalization in neonatal intensive care units (NICUs). Previous studies have reported that vitamin D deficiency is highly prevalent among preterm infants and may be associated with several neonatal morbidities, including sepsis, bronchopulmonary dysplasia, necrotizing enterocolitis, and retinopathy of prematurity [2]. In addition to its metabolic functions, vitamin D exerts important immunomodulatory effects through vitamin D receptors expressed on monocytes, macrophages, dendritic cells, and lymphocytes. Active vitamin D suppresses proinflammatory cytokine production while enhancing antimicrobial peptide synthesis and innate immune responses [1, 3]. Therefore, vitamin D deficiency has been increasingly linked to systemic inflammation and altered immune regulation. Recently, hemogram-derived inflammatory indices obtained from complete blood count parameters have emerged as inexpensive and practical biomarkers of systemic inflammation. NLR, PLR, MLR, SII, SIRI, and AISI have been investigated in various inflammatory and infectious diseases in both adult and pediatric populations [4, 5]. In neonatal medicine, these indices have also been evaluated as potential markers for neonatal sepsis and inflammatory conditions [6, 7]. Several studies have investigated the relationship between vitamin D deficiency and inflammatory biomarkers. In pediatric populations, vitamin D deficiency has been associated with increased hemogram-derived inflammatory indices, suggesting a potential interaction between vitamin D status and systemic inflammatory response [8]. Similarly, studies conducted in newborns demonstrated associations between 25-hydroxyvitamin D levels and hematological inflammatory markers [9]. However, data regarding the relationship between vitamin D status and novel hemogram-derived inflammatory indices in preterm infants remain limited. Considering the unique immunological immaturity of preterm infants and the high prevalence of vitamin D deficiency in this population, evaluating the relationship between vitamin D status and inflammatory indices may provide additional insight into neonatal inflammatory responses. Therefore, this study aimed to investigate the association between vitamin D levels and hemogram-derived inflammatory indices, including NLR, PLR, MLR, SII, SIRI, and AISI, in preterm infants hospitalized in the NICU. Specifically, we sought to evaluate whether vitamin D status was associated with early neonatal inflammatory and immune characteristics reflected by first-day hemogram-derived indices during the immediate postnatal adaptation period. Methods Study design and population This retrospective observational study was conducted in the NICU of a tertiary referral center. Preterm infants born at or below 34 weeks of gestation and hospitalized in the NICU between January 2024 and December 2025 were evaluated. Infants with major congenital anomalies, chromosomal abnormalities, chorioamnionitis, perinatal asphyxia, missing vitamin D measurements, incomplete hemogram or CRP data, and incomplete medical records were excluded from the study. A total of 212 preterm infants were included in the final analysis. Demographic, maternal, obstetric, and neonatal clinical data were obtained retrospectively from electronic medical records. Clinical and laboratory data Maternal age, gestational age, birth weight, sex, delivery mode, multiple pregnancy, antenatal steroid exposure, maternal diseases, birth season, and early-onset sepsis status were recorded. Maternal diseases included gestational diabetes mellitus, gestational hypertension, preeclampsia, preterm premature rupture of membranes (PPROM), hypothyroidism, urinary tract infection and cholestasis. Infants were classified as small for gestational age (SGA), appropriate for gestational age (AGA), or large for gestational age (LGA) according to sex-specific INTERGROWTH-21st standards [10]. Serum 25(OH)D concentrations were measured using a chemiluminescent immunoassay (CLIA) method on the Siemens Atellica IM 1600 Immunoassay Analyzer (Siemens Healthineers, Erlangen, Germany) in the hospital’s central biochemistry laboratory. All analyses were performed according to the manufacturer’s instructions and the laboratory’s internal quality-control procedures. Serum 25(OH)D levels measured during the first postnatal week were recorded. CBC parameters and CRP levels obtained on the first day of life were analyzed. WBC count, neutrophil, lymphocyte, monocyte, and platelet counts were collected from hemogram analyses. Vitamin D status was classified according to serum 25(OH)D levels as follows: deficiency: <12 ng/mL deficiency: <12 ng/mL insufficiency: 12–20 ng/mL insufficiency: 12–20 ng/mL sufficiency: ≥20 ng/mL sufficiency: ≥20 ng/mL Hemogram-Derived Inflammatory Indices Absolute WBC, neutrophil, lymphocyte, monocyte, and platelet counts were expressed as ×10³/µL. The following hemogram-derived inflammatory indices were calculated using CBC parameters: NLR = neutrophil count / lymphocyte count NLR = neutrophil count / lymphocyte count PLR = platelet count / lymphocyte count PLR = platelet count / lymphocyte count MLR = monocyte count / lymphocyte count MLR = monocyte count / lymphocyte count SII = platelet × neutrophil / lymphocyte [11] SII = platelet × neutrophil / lymphocyte [11] SIRI = neutrophil × monocyte / lymphocyte [12] SIRI = neutrophil × monocyte / lymphocyte [12] AISI = platelet × neutrophil × monocyte / lymphocyte [13] AISI = platelet × neutrophil × monocyte / lymphocyte [13] Statistical analysis Statistical analyses were performed using SPSS version 28.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were expressed as mean ± standard deviation, median [interquartile range (IQR)], or number and percentage, as appropriate. The distribution of continuous variables was assessed using the Shapiro–Wilk test. Normally distributed variables were compared using independent samples t-test or one-way ANOVA, whereas non-normally distributed variables were compared using Mann–Whitney U or Kruskal–Wallis tests. Accordingly, variables with non-normal distribution in Tables 2 and 3 are presented as median [IQR]. Categorical variables were compared using chi-square or Fisher’s exact tests. Table 2Laboratory findings and hemogram-derived inflammatory indices according to vitamin D statusVariableDeficient (< 12 ng/mL) n = 103Insufficient (12–20 ng/mL) n = 62Sufficient (≥ 20 ng/mL) n = 47p valueWBC (×10³/µL)10.4 [7.5–14.3]9.7 [7.9–13.6]9.1 [6.9–12.5]0.315Neutrophil (×10³/µL)4.4 [2.6–8.1]4.1 [3.0–6.6]4.4 [3.0–6.2]0.812Lymphocyte (×10³/µL)3.8 [2.9–5.5]4.0 [3.4–5.6]3.5 [2.7–5.0]0.205Monocyte (×10³/µL)0.73 [0.46–0.94]0.71 [0.43–1.10]0.70 [0.44–1.16]0.954Platelet (×10³/µL)254 [212–299]262 [186–305]264 [210–297]0.948CRP (mg/L)0.50 [0.50–0.50]0.50 [0.50–0.59]0.50 [0.50–0.78]0.822NLR1.12 [0.65–2.14]1.10 [0.65–1.86]1.35 [0.62–2.00]0.818PLR64.1 [49.0–90.2]60.8 [39.0–85.8]66.2 [55.7–83.7]0.229MLR0.17 [0.10–0.27]0.16 [0.10–0.28]0.17 [0.11–0.28]0.716SII299.8 [163.6–579.3]220.7 [132.9–508.3]319.0 [145.4–523.8]0.754SIRI856.6 [321.3–1856.2]612.2 [284.8–1767.3]747.4 [314.7–1796.0]0.937AISI198.2 [67.6–508.4]180.9 [70.5–452.3]206.7 [88.8–450.5]0.915Data are presented as median [interquartile range (IQR)]. Normality was assessed using the Shapiro–Wilk test. Comparisons among vitamin D groups were performed using the Kruskal–Wallis testWBCwhite blood cell count, CRPC-reactive protein, NLRneutrophil-to-lymphocyte ratio, PLR>platelet-to-lymphocyte ratio, MLRmonocyte-to-lymphocyte ratio, SIIsystemic immune-inflammation index, SIRIsystemic inflammation response index, AISIaggregate index of systemic inflammation, IQR interquartile range Laboratory findings and hemogram-derived inflammatory indices according to vitamin D status Data are presented as median [interquartile range (IQR)]. Normality was assessed using the Shapiro–Wilk test. Comparisons among vitamin D groups were performed using the Kruskal–Wallis test WBCwhite blood cell count, CRPC-reactive protein, NLRneutrophil-to-lymphocyte ratio, PLR>platelet-to-lymphocyte ratio, MLRmonocyte-to-lymphocyte ratio, SIIsystemic immune-inflammation index, SIRIsystemic inflammation response index, AISIaggregate index of systemic inflammation, IQR interquartile range Table 3Comparison of demographic and inflammatory characteristics according to gestational age subgroupVariable< 32 weeks (n = 96) Median [IQR] or n (%)≥ 32 weeks (n = 116) Median [IQR] or n (%)p valueMaternal age (years)28.5 [24.0–33.0]28.0 [25.0–34.3]0.757Birth weight (g)1229.5 [922.5–1435.0]2115.0 [1828.8–2338.8]< 0.001Vitamin D (ng/mL)13.0 [9.7–20.0]12.0 [7.4–20.0]0.390CRP (mg/L)0.50 [0.50–0.60]0.50 [0.50–0.58]0.492Lymphocyte (×10³/µL)3.70 [2.60–5.16]3.90 [3.06–5.53]0.194Platelet (×10³/µL)239.5 [175.3–285.0]268.5 [221.0–313.0]0.001NLR1.45 [0.88–2.34]0.84 [0.46–1.58]< 0.001SII383.5 [190.9–624.5]182.6 [96.9–328.3]< 0.001SIRI1112.2 [470.1–2489.7]488.9 [170.5–1315.7]< 0.001AISI320.2 [109.1–692.7]109.0 [39.7–273.7]< 0.001Cesarean section, n (%)88 (91.7)92 (79.3)0.021SGA, n (%)35 (36.5)12 (10.3)< 0.001Complete antenatal steroid course, n (%)51 (53.1)37 (31.9)0.008Maternal hypertensive disorders, n (%)20 (20.8)24 (20.7)0.981PPROM, n (%)11 (11.5)11 (9.5)0.629Data are presented as median [interquartile range (IQR)] and n (%). Normality was assessed using the Shapiro–Wilk test. Comparisons between groups were performed using the Mann–Whitney U test for continuous variables and the chi-square test or Fisher’s exact test for categorical variables, as appropriateCRP C-reactive protein, NLR neutrophil-to-lymphocyte ratio, SII systemic immune-inflammation index, SIRI systemic inflammation response index, AISI aggregate index of systemic inflammation, SGA small for gestational age, PPROM preterm premature rupture of membranes, IQR interquartile range Comparison of demographic and inflammatory characteristics according to gestational age subgroup Data are presented as median [interquartile range (IQR)] and n (%). Normality was assessed using the Shapiro–Wilk test. Comparisons between groups were performed using the Mann–Whitney U test for continuous variables and the chi-square test or Fisher’s exact test for categorical variables, as appropriate CRP C-reactive protein, NLR neutrophil-to-lymphocyte ratio, SII systemic immune-inflammation index, SIRI systemic inflammation response index, AISI aggregate index of systemic inflammation, SGA small for gestational age, PPROM preterm premature rupture of membranes, IQR interquartile range Spearman correlation analysis was used to evaluate the relationship between serum 25(OH)D levels and inflammatory indices. To evaluate whether serum vitamin D level was independently associated with hemogram-derived inflammatory indices, multivariable linear regression analyses were performed with NLR, SII, SIRI, and AISI as dependent variables. Serum 25(OH)D concentration was entered as the main explanatory variable. Gestational age, fetal growth status, delivery mode, antenatal steroid exposure, early-onset sepsis, and birth season were included as potential confounding variables. A two-sided p value < 0.05 was considered statistically significant. Results A total of 340 preterm infants born at or below 34 weeks of gestation were screened for eligibility. After exclusion of infants with exitus (n = 37), major congenital anomalies (n = 7), missing hemogram/CRP parameters (n = 24), missing vitamin D data (n = 31), chorioamnionitis (n = 4), asphyxia (n = 4), and incomplete medical records (n = 21), a total of 212 preterm infants were included in the final analysis (Fig. 1). Study flow diagram of patient selection and inclusion process A total of 212 preterm infants born between 24 and 34 weeks of gestation were included in the study. The mean gestational age was 31.1 ± 2.8 weeks and the mean birth weight was 1695.9 ± 595.0 g. The mean serum vitamin D level was 15.4 ± 10.3 ng/mL. Vitamin D deficiency, insufficiency, and sufficiency were detected in 44.3%, 27.8%, and 27.8% of infants, respectively. Demographic and clinical characteristics of the study population according to vitamin D status are presented in Table 1. Maternal age was significantly higher in the vitamin D sufficient group compared with the deficient and insufficient groups (p = 0.030). Birth season distribution also differed significantly among groups, with a higher proportion of autumn births in the vitamin D deficient group (p = 0.014). No significant differences were observed regarding gestational age, birth weight, sex, delivery mode, multiple pregnancy, maternal disease, antenatal steroid exposure, early-onset sepsis (EOS), or culture positivity rates between vitamin D groups (all p > 0.05). Table 1Baseline demographic and clinical characteristics according to vitamin D statusVariableDeficient (< 12 ng/mL) n = 94Insufficient (12–20 ng/mL) n = 59Sufficient (≥ 20 ng/mL) n = 59 p Maternal age (years)28.4 ± 5.828.8 ± 6.731.1 ± 6.00.030Gestational age (weeks)31.1 ± 2.930.6 ± 3.031.5 ± 2.20.336Birth weight (g)1728 ± 6351585 ± 5781756 ± 5380.248Female sex, n (%)33 (35.1)32 (54.2)24 (40.7)0.064Cesarean section, n (%)78 (83.0)49 (83.1)52 (89.7)0.486Multiple pregnancy, n(%)23 (24.5)12 (20.3)21 (35.6)0.145Maternal disease, n (%)37 (39.4)26 (44.1)24 (40.7)0.845Antenatal steroid (2 doses), n (%)40 (42.6)22 (37.3)26 (44.1)0.651EOS, n(%)17 (18.1)12 (20.3)16 (27.1)0.405Culture positivity, n (%)3 (3.2)3 (5.1)6 (10.2)0.187Spring birth, n (%)22 (23.4)15 (25.4)17 (28.8)Summer birth, n(%)16 (17.0)17 (28.8)14 (23.7)Autumn birth, n(%)40 (42.6)10 (16.9)12 (20.3)Winter birth, n (%)16 (17.0)17 (28.8)16 (27.1)0.014Data are presented as mean ± standard deviation or n (%). Comparisons were performed using one-way ANOVA, Kruskal–Wallis test, Pearson’s chi-square test, or Fisher’s exact test, as appropriate. EOS, early-onset sepsis Baseline demographic and clinical characteristics according to vitamin D status Data are presented as mean ± standard deviation or n (%). Comparisons were performed using one-way ANOVA, Kruskal–Wallis test, Pearson’s chi-square test, or Fisher’s exact test, as appropriate. EOS, early-onset sepsis Laboratory findings and hemogram-derived inflammatory indices according to vitamin D status are summarized in Table 2. WBC count, neutrophil, lymphocyte, monocyte, platelet count, and CRP levels were similar among the groups (all p > 0.05). Likewise, no significant differences were detected regarding NLR, PLR, MLR, SII, SIRI, or AISI values between vitamin D groups (all p > 0.05). Subgroup analyses according to gestational age (< 32 vs. ≥ 32 weeks) are shown in Table 3. Infants born before 32 weeks had significantly lower birth weights and platelet counts compared with infants born at or after 32 weeks (p < 0.05 for all). CRP levels were similar between groups (p = 0.138). Hemogram-derived inflammatory indices including NLR, SII, SIRI, and AISI were significantly higher in infants born before 32 weeks (all p < 0.01). In addition, cesarean delivery, SGA status, and complete antenatal steroid exposure were significantly more common in the < 32-week group (all p < 0.05). Maternal hypertensive disorders and PPROM rates were similar between gestational age subgroups. Spearman correlation analyses demonstrated no significant correlations between serum 25(OH)D concentrations and CRP (r = 0.051, p = 0.457), NLR (r=-0.022, p = 0.750), PLR (r = 0.027, p = 0.696), MLR (r = 0.021, p = 0.765), SII (r=-0.017, p = 0.810), SIRI (r=-0.031, p = 0.653), or AISI (r=-0.030, p = 0.662). To further evaluate the independent association between vitamin D status and inflammatory indices, multivariable linear regression analyses were performed after adjustment for gestational age, fetal growth status, delivery mode, antenatal steroid exposure, sepsis, and birth season (Table 4). Serum vitamin D level was not independently associated with NLR (β = 0.001, p = 0.896), SII (β = 0.003, p = 0.638), SIRI (β=−0.005, p = 0.567), or AISI (β=−0.004, p = 0.680). Table 4Multivariable linear regression analyses evaluating the association between vitamin D level and hemogram-derived inflammatory indicesDependent variableβ coefficient for vitamin DStandard Error95% CI p NLR0.0010.009−0.016–0.0180.896SII0.0030.006−0.009–0.0150.638SIRI−0.0050.010−0.024 − 0.0130.567AISI−0.0040.010−0.024 − 0.0160.680Multivariable linear regression models were adjusted for gestational age, fetal growth status (SGA/AGA/LGA), delivery mode, antenatal steroid exposure, sepsis, and birth season. β coefficients represent the change in each inflammatory index per 1 ng/mL increase in serum 25(OH)D concentrationCI confidence interval, NLR neutrophil-to-lymphocyte ratio, SII systemic immune-inflammation index, SIRI systemic inflammation response index, AISI aggregate index of systemic inflammation Multivariable linear regression analyses evaluating the association between vitamin D level and hemogram-derived inflammatory indices Multivariable linear regression models were adjusted for gestational age, fetal growth status (SGA/AGA/LGA), delivery mode, antenatal steroid exposure, sepsis, and birth season. β coefficients represent the change in each inflammatory index per 1 ng/mL increase in serum 25(OH)D concentration CI confidence interval, NLR neutrophil-to-lymphocyte ratio, SII systemic immune-inflammation index, SIRI systemic inflammation response index, AISI aggregate index of systemic inflammation Discussion In the present study, we investigated the association between vitamin D status and hemogram-derived inflammatory indices in preterm infants hospitalized in the NICU. Although vitamin D deficiency was highly prevalent in our cohort, serum vitamin D levels were not associated with CRP, NLR, PLR, MLR, SII, SIRI, or AISI values. In contrast, inflammatory indices including NLR, SII, SIRI, and AISI were significantly higher in infants born before 32 weeks’ gestation. However, these findings should be interpreted cautiously, as differences in gestational maturity and perinatal characteristics may have contributed to the observed differences. Vitamin D has increasingly been recognized as an important immunomodulatory hormone in addition to its role in calcium and bone metabolism. Vitamin D receptors are expressed on monocytes, macrophages, dendritic cells, and activated lymphocytes, and active vitamin D regulates both innate and adaptive immune responses through suppression of proinflammatory cytokines and enhancement of antimicrobial peptide synthesis. Previous experimental and clinical studies demonstrated that vitamin D deficiency may contribute to dysregulated inflammatory responses and increased susceptibility to infections [1, 3]. Preterm infants are particularly vulnerable to vitamin D deficiency because most placental vitamin D transfer occurs during the third trimester of pregnancy. Limited vitamin D stores at birth, inadequate enteral intake, prolonged hospitalization, and reduced sunlight exposure further increase the risk of deficiency in this population. Several neonatal studies reported associations between low vitamin D levels and neonatal morbidities including EOS, bronchopulmonary dysplasia, respiratory distress syndrome, and necrotizing enterocolitis [14, 15]. In our cohort, vitamin D deficiency and insufficiency were detected in more than two-thirds of preterm infants, supporting previous reports indicating a high prevalence of vitamin D deficiency among premature neonates. Recently, hemogram-derived inflammatory indices such as NLR, PLR, SII, and SIRI have emerged as inexpensive and readily available markers of systemic inflammation. These indices have been associated with inflammatory and infectious conditions in adult, pediatric, and neonatal populations and have also been investigated in prematurity-related morbidities, including neonatal sepsis and retinopathy of prematurity. Recent studies in preterm infants further suggest that increased inflammatory indices may be associated with lower gestational age and inflammation-related prematurity complications [6, 16, 17]. Elevated NLR and SII values have also been associated with poorer clinical outcomes and increased inflammatory burden in critically ill patients and neonatal sepsis. Since these indices can be calculated from routinely obtained CBC’s, they may provide useful information without additional blood sampling in fragile preterm infants. Despite the immunomodulatory effects of vitamin D, we did not observe significant differences in inflammatory indices according to vitamin D status. Similarly, correlation analyses revealed no significant associations between serum vitamin D levels and CRP or hemogram-derived inflammatory markers. Consistent with our findings, Say et al. reported that although early- and late-onset sepsis rates were higher in premature infants with very low vitamin D levels, vitamin D was not an independent risk factor after adjustment for gestational age and birth weight [18]. These findings suggest that gestational immaturity and prematurity-related factors may play a more dominant role than vitamin D status alone in neonatal inflammatory and infectious processes. Therefore, the absence of a significant association between vitamin D status and inflammatory indices should not be interpreted as a lack of inflammatory vulnerability in preterm infants. Hemogram parameters were obtained on the first postnatal day because the primary aim of the study was to evaluate early neonatal inflammatory status during the immediate postnatal adaptation period. First-day CBC measurements were available for all infants as part of routine clinical care, providing a standardized assessment point across the cohort. Nevertheless, serial measurements obtained closer to the timing of vitamin D assessment might have yielded different results and should be evaluated in future prospective studies. Another possible explanation may be related to the vitamin D cutoff values used for defining deficiency and insufficiency. In the present study, vitamin D status was classified according to widely accepted pediatric thresholds originally established for skeletal health and the prevention of nutritional rickets [19, 20]. However, the optimal serum 25(OH)D concentrations required for immune regulation in preterm infants remain uncertain. Therefore, thresholds developed primarily for skeletal metabolism may not accurately reflect immunological sufficiency in premature infants. Although these categories provide a standardized framework for comparison with previous neonatal and pediatric studies, they may not fully capture the complex relationship between vitamin D status and immune function during the early neonatal period. In addition, serum vitamin D concentrations were measured during the first postnatal week, a period during which vitamin D levels largely reflect maternal-fetal transfer and early postnatal metabolic adaptation. Therefore, a single early measurement may not adequately capture the longitudinal immunomodulatory effects of vitamin D as preterm infants mature. Although vitamin D supplementation was initiated only after blood sampling in our NICU, the measured concentrations may still represent a combination of prenatal vitamin D status and early postnatal physiological influences. This should be considered when interpreting the observed lack of association between vitamin D status and inflammatory indices. These factors may partially explain the absence of significant associations between vitamin D status and hemogram-derived inflammatory indices in our cohort. In contrast, several pediatric studies have demonstrated significant associations between low vitamin D levels and elevated inflammatory biomarkers, including NLR, PLR, and other hemogram-derived inflammatory indices [8, 21]. Likewise, studies conducted in newborns also reported relationships between 25-hydroxyvitamin D levels and hematological inflammatory markers [9]. The discrepancy between our findings and those reported in older pediatric populations may be related to the unique immunological characteristics of preterm infants. The preterm neonatal immune system is functionally immature and characterized by impaired neutrophil storage pools, reduced chemotaxis, altered cytokine responses, and insufficient adaptive immune regulation [22, 23]. Therefore, inflammatory responses in premature infants may be influenced by gestational maturity and perinatal factors in addition to vitamin D status during the early postnatal period. An important finding of our study was the significant differences in NLR, SII, SIRI, and AISI values between gestational age subgroups. Previous studies evaluating CBC-derived inflammatory markers in spontaneous preterm labor support the role of inflammation in prematurity-related processes. In addition, extremely preterm infants have been reported to exhibit altered inflammatory responses related to immunological immaturity and increased antenatal inflammatory exposure [24–26]. However, hemogram-derived inflammatory indices should not be interpreted solely as markers of inflammatory activation in preterm infants. These indices may also be influenced by hematological maturation, antenatal steroid exposure, perinatal stress, and early postnatal adaptation. Therefore, the observed differences across gestational age groups likely reflect a complex interaction between developmental and inflammatory processes. Importantly, the absence of an association between vitamin D status and inflammatory indices persisted after adjustment for gestational age, fetal growth status, delivery mode, antenatal steroid exposure, EOS, and birth season. These findings suggest that serum vitamin D level was not an independent determinant of early neonatal inflammatory markers in our cohort. The consistency between unadjusted and adjusted analyses further supports the robustness of our findings. In this cohort, hemogram-derived inflammatory indices appeared to be more closely associated with gestational age and perinatal characteristics than with vitamin D status. However, these findings should be interpreted cautiously, as the present study was not designed to directly compare the relative contributions of these factors and residual confounding cannot be excluded. The strengths of this study include evaluation of multiple novel hemogram-derived inflammatory indices, simultaneous assessment of CRP levels to exclude major differences in acute inflammatory burden. To our knowledge, this is one of the few studies evaluating the relationship between vitamin D status and novel hemogram-derived inflammatory indices including SII, SIRI, and AISI in preterm infants. In addition, all laboratory parameters were obtained during the early neonatal period, providing a relatively homogeneous evaluation period. Several additional limitations should be acknowledged. Infants who died during hospitalization and those with chorioamnionitis or perinatal asphyxia were excluded because these conditions are strongly associated with systemic inflammation and may substantially alter hemogram-derived inflammatory indices. Our aim was to minimize major inflammation-related confounders and to evaluate the association between vitamin D status and inflammatory indices in a more clinically homogeneous preterm population. However, this approach may limit the generalizability of the findings. In addition, although CBC and CRP measurements were obtained on the first postnatal day, serum 25(OH)D levels were measured during the first postnatal week. Therefore, a temporal mismatch between inflammatory marker assessment and vitamin D measurement cannot be excluded. Furthermore, detailed information regarding nutritional intake before vitamin D measurement was not consistently available because of the retrospective design. Although vitamin D supplementation was initiated only after blood sampling in our NICU, the potential influence of early nutritional factors cannot be completely excluded. Despite adjustment for several clinical variables, residual confounding remains possible. Finally, although the study included a relatively large cohort of preterm infants, small effect sizes may have remained undetected, and the absence of statistically significant associations should therefore be interpreted with appropriate caution. In conclusion, vitamin D status was not associated with hemogram-derived inflammatory indices in preterm infants during the first postnatal week. This lack of association persisted after adjustment for gestational age, fetal growth status, delivery mode, antenatal steroid exposure, EOS, and birth season. Although some hemogram-derived inflammatory indices differed between gestational age subgroups, these findings should be interpreted cautiously because they may reflect differences in gestational maturity and perinatal characteristics rather than inflammatory activation alone. Further prospective multicenter studies with serial measurements are needed to better clarify the relationship between vitamin D status and inflammatory profiles in preterm infants. Acknowledgements ChatGPT (OpenAI-5.2) was used exclusively for text organization and linguistic refinement. The authors confirm that all intellectual and scientific content, data interpretation, and final conclusions are entirely their own responsibility. Clinical trial registration Not applicable. Abbreviations Aggregate Index of Systemic Inflammation Appropriate for Gestational Age Complete Blood Count Confidence Interval C-reactive Protein Preterm premature rupture of membranes Gestational Age Large for Gestational Age Monocyte-to-Lymphocyte Ratio Neonatal Intensive Care Unit Neutrophil-to-Lymphocyte Ratio Odds Ratio Platelet-to-Lymphocyte Ratio Preterm Premature Rupture of Membranes Small for Gestational Age Systemic Immune-Inflammation Index Systemic Inflammation Response Index 25-hydroxyvitamin D White Blood Cell Count Authors' contributions D.K. designed the study, supervised the research process, performed data interpretation, and wrote the main manuscript text. A.I.Ö., B.C. and H.Ç. contributed to patient follow-up, data collection, and clinical data verification. B.O. and Z.Ü.O. performed statistical analysis and assisted in data interpretation. D.B. contributed to data collection and manuscript revision. All authors reviewed the manuscript critically for important intellectual content and approved the final version. Funding The authors received no external funding for this study. Data availability The datasets generated and/or analyzed during the current study are not publicly available due to institutional and patient privacy regulations but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study protocol was approved by the Ethics Committee of University of Health Sciences Haseki Training and Research Hospital. (Approval No: 70-2026). The study was conducted in accordance with the principles of the Declaration of Helsinki. Due to the retrospective design of the study and the use of anonymized clinical data, the requirement for informed consent to participate was waived by the Ethics Committee of University of Health Sciences Haseki Training and Research Hospital, including consent from the parents or legal guardians of participants younger than 16 years of age. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available due to institutional and patient privacy regulations but are available from the corresponding author on reasonable request.